Federated Hermes, Inc. Gossamer Bio, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 3,065,136 shares of GOSS stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,065,136

Previous 3,065,136 -0.0%

Holding current value

$2.27 Million

Previous $2.76 Million 10.01%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$0.51 - $1.27 $34,668 - $86,332	-67,978 Reduced 2.17%	3,065,136 $2.76 Million
Q1 2024 May 14, 2024	SELL	$0.8 - $1.51 $58,676 - $110,752	-73,346 Reduced 2.29%	3,133,114 $3.7 Million
Q4 2023 Jan 31, 2024	SELL	$0.48 - $1.08 $378,366 - $851,324	-788,263 Reduced 19.73%	3,206,460 $2.92 Million
Q3 2023 Nov 13, 2023	BUY	$0.78 - $1.82 $2.38 Million - $5.56 Million	3,057,419 Added 326.19%	3,994,723 $3.32 Million
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $3,038 - $4,744	-3,101 Reduced 0.33%	937,304 $1.12 Million
Q1 2023 May 08, 2023	BUY	$0.96 - $2.92 $229,162 - $697,036	238,711 Added 34.02%	940,405 $1.18 Million
Q4 2022 Feb 13, 2023	SELL	$1.74 - $12.87 $2.6 Million - $19.3 Million	-1,496,621 Reduced 68.08%	701,694 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $9.58 Million - $19.8 Million	-1,328,163 Reduced 37.66%	2,198,315 $26.3 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $4.76 Million - $7.05 Million	564,236 Added 19.05%	3,526,478 $30.6 Million
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $80 - $112	8 Added 0.0%	2,962,242 $33.5 Million
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $246 - $449	34 Added 0.0%	2,962,234 $37.2 Million
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $4 Million - $4.88 Million	-500,000 Reduced 14.44%	2,962,200 $24.1 Million
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $19,676 - $24,943	-2,280 Reduced 0.07%	3,462,200 $32 Million
Q4 2020 Feb 12, 2021	BUY	$8.3 - $13.59 $12 Million - $19.6 Million	1,445,443 Added 71.59%	3,464,480 $33.5 Million
Q3 2020 Nov 12, 2020	BUY	$11.3 - $14.75 $1.41 Million - $1.84 Million	124,479 Added 6.57%	2,019,037 $25.1 Million
Q2 2020 Aug 13, 2020	BUY	$9.52 - $15.98 $3.59 Million - $6.03 Million	377,358 Added 24.87%	1,894,558 $24.6 Million
Q1 2020 May 13, 2020	BUY	$8.0 - $15.48 $2.92 Million - $5.65 Million	365,000 Added 31.68%	1,517,200 $15.4 Million
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $3.27 Million - $5.91 Million	220,771 Added 23.7%	1,152,200 $18 Million
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $3.12 Million - $4.43 Million	193,429 Added 26.21%	931,429 $20.7 Million
Q1 2019 May 10, 2019	BUY	$17.58 - $23.97 $13 Million - $17.7 Million	738,000 New	738,000 $16 Million

Others Institutions Holding GOSS

# of Institutions

108

Shares Held

167M

Call Options Held

430K

Put Options Held

519K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $69.5M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Gossamer Bio, Inc. Transaction History